Oral Health Care Protects Teeth During Buprenorphine Treatment

Buprenorphine treatment remains one of the most effective tools available for opioid use disorder, and the Food and Drug Administration has stated that its benefits clearly outweigh its risks. It has also flagged a side effect that catches many people off guard. Tablets and films that dissolve in the mouth have been linked to serious dental problems, including tooth decay, cavities, oral infections, and tooth loss. Focusing on oral health in buprenorphine treatment is key.

The practical takeaway is not to stop the medication. It is to add a dentist to the care team from day one.

Why Medical Detox Matters Before Buprenorphine Treatment

Buprenorphine is a partial opioid agonist. It reduces withdrawal symptoms and the desire to use opioids without producing the cycle of highs and lows that comes with opioid misuse, and at appropriate doses it blunts the effects of other opioids.

Starting it correctly matters. Beginning buprenorphine too soon after the last opioid dose can trigger precipitated withdrawal, which is why induction is done under clinical supervision rather than improvised at home. Medical detox establishes the right timing, dose, and monitoring before a person transitions into ongoing medication-assisted treatment.

What the FDA Found

Reviewing its adverse event reporting system and published medical literature, the FDA identified 305 cases of dental problems associated with buprenorphine medicines dissolved in the mouth. Of those, 131 were classified as serious.

The average patient age was about 42, with cases ranging from 18 to 71 years old. In 26 cases, patients had no prior history of dental problems. Most involved people taking buprenorphine for opioid use disorder, though 28 cases involved products indicated for pain.

Timing varied widely. Some dental problems appeared as soon as two weeks after treatment began, while the median time to diagnosis was roughly two years. Of the 305 cases, 113 involved two or more teeth. Tooth extraction was the most common treatment, reported in 71 cases, with others requiring root canals, dental surgery, crowns, or implants.

Because these figures come from voluntary reporting and published case reports, they represent identified cases rather than a measured rate. The FDA has said it cannot determine how likely any individual is to experience these effects.

Understanding Which Products Are Affected

The concern applies to transmucosal buprenorphine, meaning tablets and films placed under the tongue or against the inside of the cheek and held there until dissolved. These are sold as single-ingredient products and in combination with naloxone, under brand names including Suboxone, Subutex, Zubsolv, Belbuca, Bunavail, and Cassipa, as well as generics.

The FDA has not identified a dental concern with buprenorphine delivered by other routes, including the skin patch and the long-acting injection. For someone with significant existing dental disease, that difference is worth raising with a prescriber.

Oral Care Steps That Protect Teeth

The FDA now requires oral health guidance in the prescribing information and patient Medication Guide for these products. The steps are straightforward:

• After the medicine has fully dissolved, take a large sip of water, swish it gently around the teeth and gums, and swallow.
• Wait at least one hour before brushing. Brushing immediately can cause mechanical damage while the mouth has not yet returned to its normal state.
• Schedule a dental visit soon after starting the medication and tell the dentist you are taking buprenorphine so they can build a decay prevention plan.
• Keep regular dental checkups going throughout treatment, and report any tooth or gum problems to both the prescriber and the dentist promptly.

Clinicians are advised to ask about oral health history before prescribing and to refer patients for a baseline dental evaluation and caries risk assessment.

Never Stop Buprenorphine on Your Own

This point carries real risk. Stopping buprenorphine abruptly can cause withdrawal, because the body has adapted to the medication, and it can lead to a return to opioid use with overdose and death as possible outcomes.

Anyone worried about dental side effects should raise the concern with their prescriber rather than taper or discontinue independently. There are options, including switching to a non-transmucosal formulation, and those decisions belong with a clinician.

Finding Medical Detox and Buprenorphine Treatment

If you are looking for a program, ask whether it provides medically supervised withdrawal management, whether buprenorphine can be started at the first visit or after a wait, and whether the program coordinates dental and primary care alongside medication.

Detox.com lists medically supervised detox centers and opioid treatment programs with details on services, medications offered, and payment. For free, confidential help finding treatment, call SAMHSA’s National Helpline at 1-800-662-4357, available 24 hours a day. If you or someone you know is in crisis, call or text 988 to reach the Suicide and Crisis Lifeline.